Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 04, 2021 at 02:07 pm EDT
Enzon Pharmaceuticals, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 381,000 compared to USD 2,000 a year ago. Operating income was USD 11,000 compared to operating loss of USD 240,000 a year ago. Net income was USD 11,000 compared to net loss of USD 242,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.